FWIA
AEGR

Fort Washington Investment Advisors’s Aegerion Pharmaceuticals AEGR Stock Holding History

Fort Washington Investment Advisors’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-41,390
Closed -$2.94M – 521
2013
Q4 		$2.94M Sell
41,390
-1,230
-3% -$94.1K 0.07% 197
2013
Q3 		$3.65M Buy
42,620
+3,215
+8% +$273K 0.09% 171
2013
Q2 		$2.5M Buy
+39,405
New +$2.09M 0.06% 241

Other funds holding AEGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Fort Washington Investment Advisors's AEGR Position: Q1 2014 in Review

Fort Washington Investment Advisors sold out of Aegerion Pharmaceuticals (AEGR) in Q1 2014, closing a stake of 41,390 shares — an estimated $2.94M sold.

Fort Washington Investment Advisors first reported a position in AEGR in Q2 2013 and held it in 3 quarters. The position peaked at $3.65M in Q3 2013. 131 funds tracked by Wall St. Rank hold AEGR as of Q1 2014.

  • Fort Washington Investment Advisors reported no remaining Aegerion Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 41,390 Aegerion Pharmaceuticals shares in Q1 2014, an estimated $2.94M.
  • Fort Washington Investment Advisors first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Fort Washington Investment Advisors's Aegerion Pharmaceuticals position peaked at $3.65M in Q3 2013.
  • 131 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q1 2014.

Based on Fort Washington Investment Advisors's 13F filing for Q1 2014, filed 13 May 2014.